F Bazerbachi1, S Haffar2, L A Szarka1, Z Wang3, L J Prokop4, M H Murad3, M Camilleri1. 1. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA. 2. Digestive Center for Diagnosis and Treatment, Damascus, Syrian Arab Republic. 3. Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA. 4. Library Public Services, Mayo Clinic, Rochester, MN, USA.
Abstract
BACKGROUND: Colonic pseudo-obstruction (CPO) is characterized by colonic distention in the absence of mechanical obstruction or toxic megacolon. Concomitant secretory diarrhea (SD) with hypokalemia (SD-CPO) due to gastrointestinal (GI) loss requires further characterization. AIM: To perform a systematic review of SD-CPO, report a case study, and compare SD-CPO with classical CPO (C-CPO). METHODS: We performed a search of MEDLINE, EMBASE, Cochrane, and Scopus for reports based on a priori criteria for CPO, SD and GI loss of potassium. An additional case at Mayo Clinic was included. RESULTS: Nine publications met inclusion criteria, with a total of 14 cases. Six studies had high, three moderate, and our case high methodological quality. Median age was 74 years (66-97), with 2:1 male/female ratio. Kidney disease was present in 6/14 patients. Diarrhea was described as profuse, watery, or viscous in 10 patients. Median serum, stool, and urine potassium concentrations (mmol/L) were 2.4 (range: 1.9-3.1), 137 (100-180), and 17 (8-40), respectively. Maximal diameter of colon and cecum (median) were 10.2 cm and 10.5 cm, respectively. Conservative therapy alone was effective in five out of 14 patients. Median potassium supplementation was 124 mEq/d (40-300). Colonic decompression was effective in three out of six patients; one had a total colectomy; three out of 14 had died. The main differences between SD-CPO and C-CPO were lower responses to treatments: conservative measures (35.7% vs 73.6%, P=.01), neostigmine (17% vs 89.2%, P<.001), and colonic decompression (50% vs 82.4%, P=.02). CONCLUSION: SD-CPO is a rare phenotype associated with increased fecal potassium and is more difficult to treat than C-CPO.
BACKGROUND:Colonic pseudo-obstruction (CPO) is characterized by colonic distention in the absence of mechanical obstruction or toxic megacolon. Concomitant secretory diarrhea (SD) with hypokalemia (SD-CPO) due to gastrointestinal (GI) loss requires further characterization. AIM: To perform a systematic review of SD-CPO, report a case study, and compare SD-CPO with classical CPO (C-CPO). METHODS: We performed a search of MEDLINE, EMBASE, Cochrane, and Scopus for reports based on a priori criteria for CPO, SD and GI loss of potassium. An additional case at Mayo Clinic was included. RESULTS: Nine publications met inclusion criteria, with a total of 14 cases. Six studies had high, three moderate, and our case high methodological quality. Median age was 74 years (66-97), with 2:1 male/female ratio. Kidney disease was present in 6/14 patients. Diarrhea was described as profuse, watery, or viscous in 10 patients. Median serum, stool, and urine potassium concentrations (mmol/L) were 2.4 (range: 1.9-3.1), 137 (100-180), and 17 (8-40), respectively. Maximal diameter of colon and cecum (median) were 10.2 cm and 10.5 cm, respectively. Conservative therapy alone was effective in five out of 14 patients. Median potassium supplementation was 124 mEq/d (40-300). Colonic decompression was effective in three out of six patients; one had a total colectomy; three out of 14 had died. The main differences between SD-CPO and C-CPO were lower responses to treatments: conservative measures (35.7% vs 73.6%, P=.01), neostigmine (17% vs 89.2%, P<.001), and colonic decompression (50% vs 82.4%, P=.02). CONCLUSION:SD-CPO is a rare phenotype associated with increased fecal potassium and is more difficult to treat than C-CPO.
Authors: Fateh Bazerbachi; Samir Haffar; Takaaki Sugihara; Taofic M Mounajjed; Naoki Takahashi; Mohammad Hassan Murad; Barham K Abu Dayyeh Journal: BMJ Open Gastroenterol Date: 2018-06-06
Authors: Inês Soler Bargiela; Maria João Gomes; Filipa Bordalo Ferreira; Ana Corte Real; Ana Sofia Ventura Journal: Eur J Case Rep Intern Med Date: 2019-07-08
Authors: Godwin K Osei-Poku; Sanya Thomas; Lawrence Mwananyanda; Rotem Lapidot; Patricia A Elliott; William B Macleod; Somwe Wa Somwe; Christopher J Gill Journal: J Glob Health Date: 2021-12-25 Impact factor: 4.413
Authors: Robert Lam; Nicholas Tarangelo; Rong Wang; Masayasu Horibe; Alyssa A Grimshaw; Dhanpat Jain; Samir Haffar; Fateh Bazerbachi; Pamela L Kunz; Darrick K Li Journal: Oncologist Date: 2022-09-02 Impact factor: 5.837
Authors: Fateh Bazerbachi; Akira Dobashi; Swarup Kumar; Sanjay Misra; Navtej S Buttar; Louis M Wong Kee Song Journal: Gastroenterol Rep (Oxf) Date: 2020-12-03